The SURE (Showcasing Undergraduate Research Excellence) conference is returning for its fourth year, taking place on 20 March.
Over 90 submissions have been received on a wide range of subjects, including discrimination and minority groups, business management and diabetes in public health, so there is something to cover all interests.
Both students and staff are encouraged to attend, whether it’s to support your friends, your students, or just hear more about the research being carried out by students at BU.
The SURE conference is an annual event which gives undergraduate students the opportunity to showcase the work they are carrying out throughout their studies at BU, whether it’s their dissertation, coursework or research carried out during their placement year. They share this either in the form of a poster, 10 minute speech or an installation. It’s a great opportunity for them to be involved in as it allows them to develop their public speaking as well as their general approach to research.
SURE 2018: book your free ticket for BU’s annual undergraduate research conference
British Conference of Undergraduate Research – abstract deadline extended










Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Boost Your Research Toolkit: Digital Confidence & AI Literacy Workshop – Friday 26 June 10am-12pm
BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease